Cell‐based tissue engineered flexor tendon allograft: A canine in vivo study
Journal of Orthopaedic Research · 2024
DOI: 10.1002/jor.25854 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Orthopaedic Research, 2024. Verfasst von Subin Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Tissue Engineering, Tendons, Allografts. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
This study aimed to compare the clinically established autologous extrasynovial tendon graft to a newly developed tissue‐engineered allograft (Eng‐allograft) in terms of functional outcomes following flexor tendon reconstruction in a canine model. The second and fifth flexor digitorum profundus (FDP) tendons from 16 dogs were transected and repaired in Zone II. After 6 weeks of cage activity, the repaired tendons were intentionally ruptured, creating a clinically relevant model for reconstruction. The re‐ruptured FDP tendons were then reconstructed using either the clinically standard autologous extrasynovial tendon graft or the Eng‐allograft, which had been revitalized with autologous bone marrow‐derived mesenchymal stem cells (BMSCs) and synovialized using carbodiimide derivatized synovial fluid (cd‐SYN). Following 12 weeks of postoperative rehabilitation, the functional outcomes of the surgical digits were evaluated. The Eng‐allograft group exhibited improved digital function, including lower digit work of flexion and reduced adhesion status, while maintaining similar tendon gliding resistance compared to the autograft group. However, the failure load of both the distal and proximal host/graft conjunctions in the Eng‐allograft group was significantly lower than that of the autograft group with higher graft rupture at the host−graft junction. In conclusion, the decellularized allogenic intrasynovial tendon, when revitalized BMSCs and synovialized with cd‐SYN, demonstrates positive effects on digital function improvement and adhesion reduction. However, the healing at both proximal and distal graft/host junctions is far lower than the autograft. Further research is needed to enhance the healing capacity of allograft conjunctions, aiming to achieve a comparable level of healing seen with autografts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Orthopedics, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
ORCID-Profile: Peter C Amadio, Chunfeng Zhao
Förderung
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Lin, S., Reisdorf, R., Lu, C. K., Wang, Z., An, K. N., Moran, S. L., Amadio, P. C., & Zhao, C. (2024). Cell‐based tissue engineered flexor tendon allograft: A canine in vivo study. Journal of Orthopaedic Research. https://doi.org/10.1002/jor.25854
Vancouver
Lin S, Reisdorf R, Lu CK, Wang Z, An KN, Moran SL, et al. Cell‐based tissue engineered flexor tendon allograft: A canine in vivo study. Journal of Orthopaedic Research. 2024. doi:10.1002/jor.25854
BibTeX
@article{Lin2024,
author = {Lin, Subin and Reisdorf, Ramona and Lu, Chun Kuan and Wang, Zhanwen and An, Kai-Nan and Moran, Steven L and Amadio, Peter C and Zhao, Chunfeng},
title = {Cell‐based tissue engineered flexor tendon allograft: A canine in vivo study},
journal = {Journal of Orthopaedic Research},
year = {2024},
doi = {10.1002/jor.25854}
}
EUVIMED